Contrasting Imation (OTCMKTS:GLAE) and ALT5 Sigma (NASDAQ:ALTS)

Imation (OTCMKTS:GLAE) and ALT5 Sigma (NASDAQ:ALTS) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability.

Insider and Institutional Ownership

6.3% of ALT5 Sigma shares are owned by institutional investors. 5.9% of Imation shares are owned by company insiders. Comparatively, 0.7% of ALT5 Sigma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Imation and ALT5 Sigma”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Imation	N/A	N/A	N/A	N/A	N/A
ALT5 Sigma	$12.53 million	17.14	-$6.24 million	N/A	N/A

Imation has higher earnings, but lower revenue than ALT5 Sigma.

Risk & Volatility

Imation has a beta of 7.44, meaning that its stock price is 644% more volatile than the S&P 500. Comparatively, ALT5 Sigma has a beta of 1.84, meaning that its stock price is 84% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Imation and ALT5 Sigma, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Imation	0	0	0	0	0.00
ALT5 Sigma	1	0	0	0	1.00

Profitability

This table compares Imation and ALT5 Sigma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Imation	N/A	N/A	N/A
ALT5 Sigma	133.06%	8.60%	7.10%

Summary

ALT5 Sigma beats Imation on 6 of the 8 factors compared between the two stocks.

About Imation

GlassBridge Enterprises, Inc., through its subsidiaries, owns and operates an asset management business in the United States. It offers investment advisory services to third party investors through managed funds separate managed accounts. The company was formerly known as Imation Corp. and changed its name to GlassBridge Enterprises, Inc. in February 2017. GlassBridge Enterprises, Inc. was incorporated in 1996 and is headquartered in New York, New York.

About ALT5 Sigma

ALT5 Sigma Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. It operates under the Biotechnology and Recycling segments. The Biotechnology segment focuses on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties. The Recycling segment is involved in a turnkey appliance recycling program. The company was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.